Author

Jennifer D. Hamilton

DUPILUMAB NORMALIZES EXPRESSION OF GENES ASSOCIATED WITH TYPE 2 INFLAMMATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
DUPILUMAB NORMALIZES EXPRESSION OF GENES ASSOCIATED WITH TYPE 2 INFLAMMATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Jennifer D. Hamilton  et al.

THE GENE EXPRESSION SIGNATURE MODULATED BY DUPILUMAB IS HIGHLY CORRELATED WITH EOSINOPHILIC ESOPHAGITIS HISTOLOGICAL SEVERITY
THE GENE EXPRESSION SIGNATURE MODULATED BY DUPILUMAB IS HIGHLY CORRELATED WITH EOSINOPHILIC ESOPHAGITIS HISTOLOGICAL SEVERITY

Jennifer D. Hamilton  et al.

DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY
DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY

Jennifer D. Hamilton  et al.

DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY
DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY

Jennifer D. Hamilton  et al.

Item 1 - 4 / 4
1